[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-343062-105":59,"doc-detail-343062-en":122},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":115,"head_meta":117,"extra_data":119,"updated_unix":121},105,"en","optimizing-the-resveratrol-fragments-for-novel-in-silico-hepatocellular-carcinoma-de-novo-drug-design","Optimizing the resveratrol fragments for novel in silico hepatocellular carcinoma de novo drug design","","Study focuses on fragment-optimizing resveratrol to support de novo drug design against hepatocellular carcinoma (HCC). The work considers key prognostic proteins involved in HCC biology, including BRAF_human, VGFR3_human, EGFR_human, and UFO_human, and evaluates docking performance of the developed FOR compound. Results indicate VEGFR3_human shows the highest binding energy with FOR (−7.6 kcal/mol) and the candidate satisfies drug-likeliness criteria. FOR is proposed as an efficient lead for future in-vivo evaluation.",{"@graph":69,"@context":114},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/optimizing-the-resveratrol-fragments-for-novel-in-silico-hepatocellular-carcinoma-de-novo-drug-design/343062/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/optimizing-the-resveratrol-fragments-for-novel-in-silico-hepatocellular-carcinoma-de-novo-drug-design/343062.png","ImageObject",300,407,{"name":92,"@type":93},"Oliver","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108],{"name":109,"@type":110,"acceptedAnswer":111},"Why is resveratrol considered relevant for hepatocellular carcinoma treatment?","Question",{"text":112,"@type":113},"Resveratrol has antioxidant, anti-inflammatory, and immune-modulating properties, and it can reduce cancer cell proliferation while promoting apoptosis.","Answer","https://schema.org",{"og:url":83,"og:type":116,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":118,"canonical":83},"index,follow",{"doc_id":120,"site_id":62},343062,1790244162,{"code":4,"msg":5,"data":123},{"doc_id":120,"user_id":124,"nickname":92,"user_avatar":125,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":126,"file_id":127,"file_url":128,"file_type":129,"file_size":130,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":131,"language":132,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":133,"faqs":134,"seo_title":135,"seo_description":67,"update_tm":136,"read_time":36,"preview_page_count":19,"preview_urls":137},8796095461610,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nOptimizing the resveratrol fragments for novel in silico hepatocellular carcinoma de novo drug design  \nMuhammad Naveed1*, Khushbakht Javed1, Tariq Aziz2*, Amina Abid1, Hafiz Muzzammel Rehman 3, MetabAlharbi4, Abdulrahman Alshammari4 &  \nAbdullah F. Alasmari4  \nHepatocellular carcinoma (HCC) incidence varies widely around the world and is impacted by factors such as the prevalence of chronic hepatitis B and C infections, alcohol intake, and access to healthcare. The proteins (BRAF_human, VGFR3_human, EGFR_human and UFO_human) play a vital role in hepatocellular carcinoma prognosis, which involves cell proliferation, cell growth, transmission of extracellular signals to the cell nucleus and consequently regulating many other cellular processes. Fostamatinib has been studied for its possible use in the treatment of hepatocellular cancer because it is a more convenient therapy choice for patients and has minor side effects on the human body. However, resveratrol phytochemical has been investigated for its potential use in the prevention and treatment of a wide range of disorders, including cancer, cardiovascular disease, diabetes, and neurological problems due to its frequently antioxidant, anti-inflammatory, and immune-modulating characteristics, which can aid in the prevention of chronic illnesses. This study developed de novobased fragment-optimized resveratrol (FOR), enhancing therapeutic potential and lowering toxicity. The docking study was performed with four target proteins, and the findings reveal that the vascular endothelial growth factor receptor 3 protein possessed the highest binding energy values of −7.6 kcal/ mol with FOR. Additionally, it completely fulfills the criteria of drug-likeliness rules. Thus, FOR proves to be an efficient drug candidate for future in-vivo studies against hepatocellular carcinoma.  \nKeywords Hepatocellulular cancer, Resveratrol, ADME, De novo drug, Fragment optimization  \nHepatocellular carcinoma (HCC) is a type of primary liver cancer that develops mostly from hepatocytes worldwide (> 500,000 deaths/year)1. It is one of the most prevalent and lethal cancers in the world, having a significant impact on public health. HCC usually occurs in the setting of chronic liver illness, notably in people with cirrhosis or chronic hepatitis B or C infections, which provide an environment favorable for tumor growth2. Alcoholism, obesity, and exposure to aflatoxins are all risk factors for HCC. Early symptoms are frequently nonexistent or non-specific, making early diagnosis difficult. Patients may have symptoms such as stomach discomfort, weight loss, jaundice, and fluid collection in the belly as advanced conditions. Curative treatments for early-stage tumors may include surgical excision or liver transplantation, however advanced stages require radiofrequency ablation, transarterial chemoembolization, or systemic treatments such as targeted medicines and immunotherapies3.  \nThe four key proteins BRAF_HUMAN, VGFR3_HUMAN, EGFR_HUMAN and UFO_HUMAN are critical in hepatocellular cancer4. BRAF is a protein kinase that is involved in the transmission of extracellular signals to the cell nucleus, consequently regulating many cellular processes. It has been estimated BRAF mutations characterize around 70% of melanoma tumors5. Vascular Endothelial Growth Factor Receptor 3, or VEGFR3_HUMAN, is a crucial protein in the processes ofangiogenesis and lymphangiogenesis, its increased expression can promote tumor development and metastasis by inducing new blood and lymphatic vessels, which in turn helps provide nutrients and spread tumor cells6. Furthermore, EGFR levels are frequently observed in hepatocellular carcinoma  \n1Department of Biotechnology, Faculty of Science and Technology, University of Central Punjab, Lahore 54590, Punjab, Pakistan. 2Laboratory of Animal Health Hygiene and Quality, University of Ioannina, 47132 Arta, Gre","cbCaihDwYTADzP4T","https://ap.wps.com/l/cbCaihDwYTADzP4T","pdf",2875475,16,"English","# Abstract\n## Hepatocellular carcinoma background and clinical context\n## Target proteins and biological roles\n## Resveratrol rationale\n## Fragment-optimized resveratrol and docking results\n## Drug-likeliness and proposed next steps","[{\"question\":\"Why is resveratrol considered relevant for hepatocellular carcinoma treatment?\",\"answer\":\"Resveratrol has antioxidant, anti-inflammatory, and immune-modulating properties, and it can reduce cancer cell proliferation while promoting apoptosis.\"}]","Optimizing the resveratrol fragments for novel in silico hepatocellular carcinoma de novo drug design | PDF",1790049674,[138,142,146,150],{"page_no":8,"url":139,"width":140,"height":141},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/24f6957a5a2732040036af33b2359206.webp",983,1291,{"page_no":14,"url":143,"width":144,"height":145},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f7f92ed405e4d6276c86dc2775ef5fb6.webp",982,1290,{"page_no":81,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dca63927beff61e59103ce3a27fe1a81.webp",981,1289,{"page_no":19,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/325c933779494dbcf0ae4b68ba532343.webp",980,1287]